| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/26/2008 | CA2672983A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
| 06/26/2008 | CA2672976A1 New combination for use in the treatment of inflammatory disorders |
| 06/26/2008 | CA2672973A1 Process for manufacturing ophthalmic oil-in-water emulsions |
| 06/26/2008 | CA2672957A1 Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity |
| 06/26/2008 | CA2672937A1 Inhibitory polynucleotide compositions and methods for treating cancer |
| 06/26/2008 | CA2672898A1 Methods of neuroprotection by cyclin-dependent kinase inhibition |
| 06/26/2008 | CA2672895A1 Use of gentian violet in treatment of atopic dermatitis |
| 06/26/2008 | CA2672893A1 Triazine derivatives and their therapeutical applications |
| 06/26/2008 | CA2672856A1 Benzimidazole trpv1 inhibitors |
| 06/26/2008 | CA2672841A1 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety |
| 06/26/2008 | CA2672828A1 Methods of treatment |
| 06/26/2008 | CA2672825A1 Cytoskeletal active rho kinase inhibitor compounds, composition and use |
| 06/26/2008 | CA2672815A1 Benzimidazole derivatives for use in treating abnormal cell growth |
| 06/26/2008 | CA2672814A1 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| 06/26/2008 | CA2672795A1 Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof |
| 06/26/2008 | CA2672792A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | CA2672776A1 2-substituted 5-membered heterocycles as scd inhibitors |
| 06/26/2008 | CA2672761A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cpti) |
| 06/26/2008 | CA2672719A1 Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors |
| 06/26/2008 | CA2672673A1 O-linked pyrimidin-4-amine-based compounds, compositions comprising them and methods of their use |
| 06/26/2008 | CA2672661A1 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 06/26/2008 | CA2672650A1 Compositions and methods for the treatment of cancer |
| 06/26/2008 | CA2672618A1 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| 06/26/2008 | CA2672616A1 Novel oxadiazole compounds |
| 06/26/2008 | CA2672598A1 Water-soluble phenicol prodrugs in a lipophilic vehicle system |
| 06/26/2008 | CA2672586A1 Water-soluble prodrugs of florfenicol and its analogs |
| 06/26/2008 | CA2672560A1 Methods for treating podocyte-related disorders |
| 06/26/2008 | CA2672521A1 Pyrazole derivatives as protein kinase inhibitors |
| 06/26/2008 | CA2672446A1 Quinuclidinol derivatives as muscarinic receptor antagonists |
| 06/26/2008 | CA2672414A1 Crystalline solid rasagiline base |
| 06/26/2008 | CA2672400A1 Gelatin capsules comprising an acid |
| 06/26/2008 | CA2672286A1 Organic compounds |
| 06/26/2008 | CA2672270A1 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 06/26/2008 | CA2672257A1 Method for improving ventilatory efficiency |
| 06/26/2008 | CA2672250A1 Antiviral indoles |
| 06/26/2008 | CA2672192A1 Inhibitors of histone deacetylase and prodrugs thereof |
| 06/26/2008 | CA2672191A1 (1r,6s)-2-azabicyclo[4.3.0] nonane-8,8-diphosphonic acid and its use in treating or preventing bone disorders, for example, osteoporosis or paget's disease |
| 06/26/2008 | CA2672059A1 Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 06/26/2008 | CA2671993A1 N-hydroxyacrylamide compounds |
| 06/26/2008 | CA2671982A1 Methods of using mek inhibitors |
| 06/26/2008 | CA2671838A1 4-imidazolines as taar's ligands |
| 06/26/2008 | CA2671837A1 Novel use of inhibitors of soluble epoxide hydrolase |
| 06/26/2008 | CA2671765A1 5- [4- (azetidin-3-yloxy) -phenyl] -2-phenyl-5h-thiazolo [5,4-c] pyridin-4-one derivatives and their use as mch receptor |
| 06/26/2008 | CA2671738A1 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer |
| 06/26/2008 | CA2671728A1 Pharmaceutical composition comprising a hot-melt granulated lubricant |
| 06/26/2008 | CA2671727A1 A composition containing a bisphosphonic acid in combination with vitamin d |
| 06/26/2008 | CA2671673A1 Angiotensin ii receptor antagonists |
| 06/26/2008 | CA2671670A1 Sustained-release composition and method for producing the same |
| 06/26/2008 | CA2671668A1 Therapeutic composition for interstitial pheumonia |
| 06/26/2008 | CA2671550A1 Heterocycle compounds and methods of use thereof |
| 06/26/2008 | CA2671535A1 Novel crystalline compound useful as glk activator |
| 06/26/2008 | CA2671530A1 Use of fluocinolone acetonide,tretinoin and hydroquinone cream in melasma maintenance therapy |
| 06/26/2008 | CA2671528A1 Use of fluocinolone acetonide,tretinion and hydroquinone cream in melasma maintenance therapy |
| 06/26/2008 | CA2671525A1 Indolylmaleimide derivatives |
| 06/26/2008 | CA2671426A1 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof |
| 06/26/2008 | CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/26/2008 | CA2671137A1 Carbonic anhydrase inhibitors derivatives |
| 06/26/2008 | CA2670839A1 Adenosine derivatives as partial and full agonists of a1 adenosine receptors |
| 06/26/2008 | CA2670730A1 Monophosphates as mutual prodrugs of anti-inflammatory signal transduction modulators (aistm's) and beta-agonists for the treatment of pulmonary inflammation and bronchoconstriction |
| 06/26/2008 | CA2667654A1 Method of providing pirfenidone therapy to a patient |
| 06/26/2008 | CA2665762A1 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 06/26/2008 | CA2662506A1 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches |
| 06/25/2008 | EP1936381A1 Ptpase inhibitors and method of using same |
| 06/25/2008 | EP1936376A2 Screening and treatment methods for prevention of preterm delivery |
| 06/25/2008 | EP1935991A2 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/25/2008 | EP1935979A2 Antigenic meningococcal peptides |
| 06/25/2008 | EP1935892A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 06/25/2008 | EP1935890A1 2-heteroaryl-substituted indole derivative |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935886A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1935883A1 Oxindole derivative as feeding control agent |
| 06/25/2008 | EP1935882A1 Bicyclic compounds |
| 06/25/2008 | EP1935881A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 06/25/2008 | EP1935879A1 Substituted cycloalkene derivative |
| 06/25/2008 | EP1935874A1 S1p3 receptor antagonist |
| 06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
| 06/25/2008 | EP1935435A2 Blood pool agents for nuclear magnetic resonance diagnostics |
| 06/25/2008 | EP1935432A1 Medical agent containing insulin resistance improving agent |
| 06/25/2008 | EP1935425A2 Immunemodulating oligosaccharides for the treatment and/or prevention of chronic obstructive pulmonary disease (COPD) |
| 06/25/2008 | EP1935424A1 Pharmaceutical compositions comprising combined antidiabetic substances for use in diabetes mellitus |
| 06/25/2008 | EP1935423A2 Composition for treating and/or prophylaxis of tumors of the breast |
| 06/25/2008 | EP1935422A1 Pharmaceutical composition comprising nicotinamide or nicotinic acid |
| 06/25/2008 | EP1935421A1 Controlled-release compositions containing opioid agonist and antagonist |
| 06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| 06/25/2008 | EP1935419A1 Hemodynamics improving agent |
| 06/25/2008 | EP1935418A1 Composition for relieving subjective symptoms of fatigue |
| 06/25/2008 | EP1935417A1 Composition for use in prevention of hypoglycemic condition |
| 06/25/2008 | EP1935416A2 Use of (Z)-2-cyano-3-Hydroxy-but-2-enoic acid-(4'-trifluorromethylphenyl)-amide for treating multiple sclerosis |
| 06/25/2008 | EP1935415A2 Treatment of androgen-deprivation induced osteoporosis |
| 06/25/2008 | EP1935414A2 Carbonic anhydrase activators for enhancig learning and memory |
| 06/25/2008 | EP1935413A1 Iontophoresis preparation for treatment of breast cancer and/or mastitis |
| 06/25/2008 | EP1935412A2 Pharmaceutical composition containing 5-chloro-1-[1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]piperidine-4-yl]-1,3-dihydro-2H-benzimidazol-2-one and method of preparing same |
| 06/25/2008 | EP1935407A1 Low viscosity liquid dosage forms |
| 06/25/2008 | EP1935406A1 Dispersible pharmaceutical formulations containing fluoxetine |
| 06/25/2008 | EP1935397A1 Oral and tooth care and cleaning agents for combating halitosis |
| 06/25/2008 | EP1934602A1 Method for detecting a biomarker of oxidative stress in a biological sample |
| 06/25/2008 | EP1934598A2 Treatment and diagnosis of obligate intracellular pathogens |
| 06/25/2008 | EP1934388A1 Method of drug design |
| 06/25/2008 | EP1934348A1 Compositions for silencing the expression of vdac1 and uses thereof |